Sarepta Therapeutics (SRPT) Intangibles (2010 - 2026)

Sarepta Therapeutics' Intangibles history runs 17 years deep, the most recent figure standing at $31.4 million for Q1 2026.

• On a quarterly basis, Intangibles rose 19.79% year-over-year to $31.4 million in Q1 2026; TTM through Mar 2026 was $31.4 million, a 19.79% increase from a year earlier, with the FY2025 full-year figure at $28.9 million, up 7.67% from the prior year.
• Intangibles rose to $31.4 million in Q1 2026 per SRPT's latest filing, from $28.9 million in the prior quarter.
• Across five years, Intangibles topped out at $31.4 million in Q1 2026 and bottomed at $7.2 million in Q1 2023.
• The 5-year median for Intangibles is $26.2 million (2025), against an average of $21.2 million.
• Across the five-year window, Intangibles slumped 46.78% in 2022 and surged 301.86% in 2024, its largest moves.
• Year by year, Intangibles stood at $7.6 million in 2022, then surged by 31.96% to $10.0 million in 2023, then soared by 168.87% to $26.9 million in 2024, then climbed by 7.67% to $28.9 million in 2025, then advanced by 8.41% to $31.4 million in 2026.
• Per Business Quant, the three latest SRPT Intangibles figures stand at $31.4 million (Q1 2026), $28.9 million (Q4 2025), and $29.7 million (Q3 2025).